Integrin α2β1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein
- 1 August 2006
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 312 (13), 2443-2453
- https://doi.org/10.1016/j.yexcr.2006.04.009
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA100145, R01 CA88931)
This publication has 30 references indexed in Scilit:
- Integrin α2β1 modulates EGF stimulation of Rho GTPase‐dependent morphological changes in adherent human rhabdomyosarcoma RD cellsJournal of Cellular Physiology, 2004
- Basement membranes: structure, assembly and role in tumour angiogenesisNature Reviews Cancer, 2003
- Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein SynthesisScience, 2002
- Towards a mechanistic understanding of tumor invasion—lessons from theα 6 β 4integrinSeminars in Cancer Biology, 2001
- Expression of VLA-2, VLA-3, and alpha v integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic valueBritish Journal of Ophthalmology, 2000
- Metastatic Dissemination of Human Ovarian Epithelial Carcinoma Is Promoted by α2β1-Integrin-Mediated Interaction with Type I CollagenInvasion and Metastasis, 1998
- Intratumoral vascularity as a prognostic factor in cancers of the urogenital tractEuropean Journal Of Cancer, 1996
- Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain.The Journal of cell biology, 1993
- Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti-beta 1 antibody.The Journal of cell biology, 1993
- Thrombospondin Promotes Cell-Substratum AdhesionScience, 1987